Antibodies and genetically engineered related molecules: Production and purification

Biotechnology Progress

Volumn 20, Issue 3, 2004, Pages 639-654

  Roque, A Cecília A ^a,b   Lowe, Christopher R ^b,c,d   Taipa, M Ângela ^a,e  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d Institute of Biotechnology ^*

^e Ctr for Biol and Chem Engineering   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

NON-PEPTIDIC LIGANDS; TUMOR CELLS;

BIOTECHNOLOGY; CELLS; GENETIC ENGINEERING; PURIFICATION; TUMORS;

MONOCLONAL ANTIBODIES;

ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL; BIOSYNTHESIS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; PHARMACEUTICS; PROTEIN ENGINEERING; REVIEW;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; BIOPHARMACEUTICS; CHROMATOGRAPHY, AFFINITY; HUMANS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

MURINAE;

EID: 2942722679     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp030070k     Document Type: Review

References (197)

1. Köhler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256, 495-497.
2. Jack, G. W.; Wade, H. E. Immunoaffinity chromatography of clinical products. Trends Biotechnol. 1987, 5, 91-95.
3. Hage, D. S. Affinity chromatography: a review of clinical applications. Clin. Chem. 1999, 45, 593-615.
4. Accoceberry, I.; Thellier, M.; Datry, A.; Desportes-Livage, I.; Biligui, S.; Danis, M.; Santarelli, X. One-step purification of Enterocytozoon bieneusi spores from human stools by immunoaffinity expanded-bed adsorption. J. Clin. Microbiol. 2001, 39, 1947-1951.
5. Muronetz, V. I.; Sholukh, M.; Korpela, T. Use of protein-protein interactions in affinity chromatography. J. Biochem. Biophys. Methods 2001, 49, 29-47.
6. Blank, K.; Lindner, P.; Diefenbach, B.; Pluckthun, A. Self-immobilizing recombinant antibody fragments for immunoaffinity chromatography: generic, parallel, and scalable protein purification. Protein Expression Purif. 2002, 24, 313-322.
7. Gupta, M. N.; Kaul, R.; Guoqiang, D.; Dissing, U.; Mattiasson, B. Affinity precipitation of proteins. J. Mol. Recognit. 1996, 9, 356-359.
8. Kumar, A.; Kamihira, M.; Galaev, I. Y.; Mattiasson, B.; Iijima, S. Type-specific separation of animal cells in aqueous two-phase systems using antibody conjugates with temperature-sensitive polymers. Biotechnol. Bioeng. 2001, 75, 570-580.
9. Fong, R. B.; Ding, Z.; Hoffman, A. S.; Stayton, P. S. Affinity separation using an Fv antibody fragment-"smart" polymer conjugate. Biotechnol. Bioeng. 2002, 79, 271-276.
10. Kasper, C.; Reif, O.; Freitag, R. Evaluation of affinity filters for protein isolation. Bioseparation 1997, 6, 373-382.
11. Klein, E. Affinity membranes: a 10-year review. J. Membr. Sci. 2000, 179, 1-27.
12. Mergulhao, F. J. M.; Monteiro, G. A.; Cabrai, J. M. S.; Taipa, M. A. A quantitative ELISA for monitoring the secretion of ZZ-fusion proteins using SpA domain as immunodetection reporter system. Mol. Biotechnol. 2001, 19, 239-244.
13. Cavrois, M.; de Noronha, C.; Greene, W. C. A sensitive and specific enzyme-assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 2002, 20, 1151-1154.
14. Safar, J. G.; Scott, M.; Monaghan, J.; Deering, C.; Didorenko, S.; Vergara, J.; Ball, H.; Legname, G.; Leclerc, E.; Solforosi, L.; Serban, H.; Groth, D.; Burton, D. R.; Prusiner, S. B.; Williamson, R. A. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and trangenic mice. Nat. Biotechnol. 2002, 20, 1147-1150.
15. Egodage, K. M.; Wilson, G. S. Antibodies as immobilization reagents. In Immobilized Biomolecules in Analysis; Cass, T., Ligler, F. S., Eds.; Oxford University Press: New York, 1998/
16. Neubert, H.; Jacoby, E. S.; Bansal, S. S.; Iles, R. K.; Cowan, D. A.; Kicman, A. T. Enhanced affinity capture MALDI-TOF MS: orientation of an immunoglobulin G using recombinant Protein G. Anal. Chem. 2002, 74, 3677-3683.
17. Renard, M.; Belkadi, L.; Hugo, N.; Englan, P.; Altschuh, D.; Bedouelle, H. Knowledge-based design of reagentless fluorescent biosensors from recombinant antibodies. J. Mol. Biol. 2002, 318, 429-442.
18. Zhu, H.; Snyder, M. Protein chip technology. Curr. Opin. Chem. Biol. 2003, 7, 55-63.
19. Quadri, S. M.; Malik, A. B.; Tang, X. Z.; Patenia, R.; Freedman, R. S.; Vriesendorp, H. M. Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12. Cancer Res. 1995, 55, 5736-5742.
20. Deonarain, M. P.; Rowlinson-Busza, G.; George, A. J. T.; Epenetos, A. A. Redesigned anti-human placental alkaline phosphatase single-chain Fv: soluble expression, characterization and in vivo tumour targeting. Protein Eng. 1997, 10, 89-98.
21. Raab, A.; Han, W.; Badt, D.; Smith-Gill, S. J.; Lindasy, S. M.; Schindler, H.; Hinterdorfer, P. Antibody recognition imaging by force microscopy. Nat. Biotechnol. 1999, 17, 902-905.
22. Waibel, R.; Alberto, R.; Willuda, J.; Finnern, R.; Schibli, R.; Stichelberger, A.; Egli, A.; Abram, U.; Mach, J. P.; Pluckthun, A.; Schubiger, P. A. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat. Biotechnol. 1999, 17, 897-901.
23. Cattaneo, A.; Biocca, S. The selection of intracellular antibodies. Trends Biotechnol. 1999, 17, 115-121.
24. Poul, M. A.; Marks, J. D. Targeted gene delivery to mammalian cells by filamentous bacteriophage. J. Mol. Biol. 1999, 288, 203-211.
25. Riechmann, L.; Clark, M.; Waldmann, H.; Winter, G. Reshaping human antibodies for therapy. Nature 1988, 332, 323-327.
26. Huls, G.; Gestel, D.; van der Linden, J.; Moret, E.; Logtenberg, T. Tumor cell killing by in vitro affinity-matured recombinant human monoclonal antibodies. Cancer Immunol. Immunother. 2001, 50, 163-171.
27. Burton, D. R. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2002, 2, 706-713.
28. Peipp, M.; Valerius, T. Bispecific antibodies targeting cancer cells. Biochem. Soc. Trans. 2002, 30, 507-511.
29. Holliger, P.; Brissinck, J.; Williams, R. L.; Thielemans, K.; Winter, G. Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody. Protein Eng. 1996, 9, 299-305.
30. Kontermann, R. E.; Wing, M. G.; Winter, G. Complement recruitment using bispecific diabodies. Nat. Biotechnol. 1997, 15, 629-631.
31. Cragg, M. S.; French, R. R.; Glennie, M. J. Signaling antibodies in cancer therapy. Curr. Opin. Immunol. 1999, 11, 541-547.
32. Cochlovius, B.; Kipriyanov, S. M.; Stassar, M.; Christ, O.; Schuhmacher, J.; Strauss, G.; Moldenhauer, G.; Little, M. Treatment of human B cell lymphoma xenografts with a CD3 x CD19 diabody and T cells. J. Immunol. 2000, 165, 888-895.
33. Izadyar, L.; Friboulet, A.; Remy, M. H.; Roseto, A.; Thomas, D. Monoclonal antiidiotypic antibodies as functional internal images of enzyme active-sites - Production of a catalytic antibody with a cholinesterase activity. Proc. Natl. Acad. Sci. U.S.A.. 1993, 90, 8876-8880.
34. Benkovic, S. J. The key is in the pocket Nature 1996, 383, 23-24.
35. Goldbaum, F. A.; Velikovsky, C. A.; DallAcqua, W.; Fossati, C. A.; Fields, B. A.; Braden, B. C.; Poljak, R. J.; Mariuzza, R. A. Characterization of anti-anti-idiotypic antibodies that bind antigen and an anti-idiotype. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 8697-8701.
36. Avalle, B.; Thomas, D.; Friboulet, A. Functional mimicry: elicitation of a monoclonal anti-idiotypic antibody hydrolizing beta-lactams. FASEB J. 1998, 12, 1055-1060.
37. Kakinuma, H.; Fujii, I.; Nishi, Y. Selective chemotherapeutic strategies using catalytic antibodies: a common promoiety for antibody directed abzyme prodrug therapy. J. Immunol. Methods 2002, 269, 269-281.
38. Zhou, Y. X.; Karle, S.; Taguchi, H.; Planque, S.; Nishiyama, Y.; Paul, S. Prospects for immunotherapeutic proteolytic antibodies. J. Immunol. Methods 2002, 269, 257-268.
39. Reichert, J. M. Monoclonal antibodies in the clinic. Nat. Biotechnol. 2001, 19, 819-822.
40. van Dijk, M. A.; van de Winkel, J. G. J. Human antibodies as next generation therapeutics. Curr. Opin. Chem. Biol. 2001, 5, 368-374.
41. Brekke, O. H.; Sandlie, I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat. Rev. Drug Discovery 2003, 2, 52-62.
42. Monzavi-Karbassi, B.; Kieber-Emmons, T. Current concepts in cancer vaccine strategies. BioTechniques 2001, 30, 170-189.
43. Sa 'Adu, A.; Zumla, A. Human monoclonal antibodies: production, use, problems. In Monoclonal Antibodies-Production, Engineering and Clinical Application; Ritter, M., Ladyman, H., Eds.; Cambridge University Press: Cambridge, 1995.
44. Winter, G.; Milstein, C. Man-made antibodies. Nature 1991, 349, 293-299.
45. Rees, A. R.; Staunton, D.; Webster, D. M.; Searle, S. J.; Henry, A. H.; Pedersen, J. T. Antibody design: beyond the natural limits. Trends Biotechnol. 1994, 12, 199-206.
46. Maynard, J.; Georgiou, G. Antibody engineering. Annu. Rev. Biomed. Eng. 2000, 2, 339-376.
47. McCafferty, J.; Glover, D. R. Engineering therapeutic proteins. Curr. Opin. Struct. Biol. 2000, 10, 417-420.
48. Ryu, D. D. Y.; Nam, D. Biomolecular engineering: a new frontier in biotechnology. J. Mol. Catal. B: Enzym. 2000, 10, 23-37.
49. Francisco, J. A.; Campbell, R.; Iverson, B. L.; Georgiou, G. Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10444-10448.
50. Gunneriusson, E.; Samuelson, P.; Uhlen, M.; Nygren, P. A.; Stahl, S. Surface display of a functional single-chain Fv antibody on Staphyloccoci. J. Bacteriol. 1996, 178, 1341-1346.
51. Boder, E. T.; Wittrup, K. D. Yeast surface display for directed evolution of protein expression, affinity, and stability. Methods Enzymol. 2000, 328, 430-444.
52. Schaffitzel, C.; Hanes, J.; Jermutus, L.; Pluckthun, A Ribosome display: an in vitro method for selection and evolution of antibodies from libraries. J. Imnmunol. Method 1999, 231, 119-135.
53. Hanes, J.; Schaffitzel, C.; Knappik, A. Pluckthun, A. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat. Biotechnol. 2000, 18, 1287-1292.
54. Irving, R. A.; Coia, G.; Roberts, A.; Nuttall, S. D.; Hudson, P. J. Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics. J. Immunol. Methods 2001, 248, 31-45.
55. FitzGerald, K. In vitro display technologies - new tools for drug discovery. Drug Discovery Today 2000, 5, 253-258.
56. Gearhart, P. J. The roots of antibody diversity. Nature 2002, 419, 29-30.
57. George, A. J. T. Production of antibodies using phage display libraries. In Monoclonal Antibodies-Production, Engineering and Clinical Application; Ritter, M., Ladyman, H., Eds.; Cambridge University Press: Cambridge, 1995.
58. Clackson, T.; Wells, J. A. In-vitro selection from protein and peptide libraries. Trends Biotechnol. 1994, 12, 173-184.
59. Knappik, A.; Ge, L.; Honegger, A.; Pack, P.; Fischer, M.; Wellnhofer, G.; Hoess, A.; Wolle, J.; Pluckthun, A.; Virnekas, B. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J. Mol. Biol. 2000, 296, 57-86.
60. Krebs, B.; Rauchenberger, R.; Reiffert, S.; Rothe, C.; Tesar, M.; Thomassen, E.; Cao, M.; Dreier, C.; Fischer, D.; Hob, A.; Inge, L.; Knappik, A.; Marget, M.; Pack, P.; Meng, X.; Schier, R.; Sohlemann, P.; Winter, J.; Wolle, J.; Kretzschmar, T. High-throughput generation and engineering of recombinant human antibodies. J. Immunol. Methods 2001, 254, 67-84.
61. Boder, E. T.; Midelfort, K. S.; Wittrupt, K. D. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 10701-10705.
62. Marks, J. D.; Griffiths, A. D.; Malmqvist, M.; Clackson, T. P.; Bye, J. M.; Winter, G. Bypassing immunization - Building high-affinity human-antibodies by chain shuffling. Biol/Technology. 1992, 10, 779-783.
63. Courtenay-Luck, N. S. Genetic manipulation of monoclonal antibodies. In Monoclonal Antibodies-Production, Engineering and Clinical Application; Ritter, M., Ladyman, H., Eds.; Cambridge University Press: Cambridge, 1995.
64. Neuberger, M. Generating high-avidity human Mabs in mice. Nat. Biotechnol. 1996, 14, 826.
65. Green, L. L. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J. Immunol. Methods 1999, 231, 11-23.
66. Tomizuka, K.; Shinoara, T.; Yoshida, H.; Uejima, H.; Ohguma, A.; Tanaka, S.; Sato, K.; Oshimura, M.; Ishida, I. Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and k loci and expression of fully human antibodies. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 722-727.
67. Reisner, Y.; Dagan, S. The trimera mouse: generating human monoclonal antibodies and an animal model for human diseases. Trends Biotechnol. 1998, 16, 242-246.
68. Kortt, A. A.; Dolezal, O.; Power, B. E.; Hudson, P. J. Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting. Biomol. Eng. 2001, 18, 95-108.
69. Chamow, S. M.; Ashkenazi, A. Antibody Fusion Proteins; John Wiley & Sons: New York, 1999.
70. Worn, A.; Pluckthun, A. Stability engineering of antibody single-chain Fv fragments. J. Mol. Biol. 2001, 305, 989-1010.
71. Wang, M.; Lee, L. S.; Nepomich, A.; Yang, J.; Conover, C.; Whitlow, M.; Filpula, D. Single-chain Fv with manifold N-glycans as bifunctional scaffolds for immunomolecules. Protein Eng. 1998, 12, 1277-1283.
72. Chapman, A. P.; Antoniw, P.; Spitali, M.; West, S.; Stephens, S.; King, D. J. Therapeutic antibody fragments with prolonged in vivo half-lifes. Nat. Biotechnol. 1999, 17, 780-783.
73. Chapman, A. P. PEGylated antibodies and antibody fragments for improved therapy: a review. Adv. Drug Delivery Rev. 2002, 54, 531-545.
74. Rondot, S.; Koch, J.; Breitling, F.; Dubel, S. A helper phage to improve single-chain presentation in phage display. Nat. Biotechnol. 2001, 19, 75-78.
75. Laukkanen, M. L.; Teeri, T. T.; Keinanen, K. Lipid-tagged antibodies - Bacterial expression and characterization of a lipoprotein single-chain antibody fusion protein. Protein Eng. 1993, 6, 449-454.
76. Carter, P. Bispecific human IgG by design. J. Immunol. Methods 2001, 248, 7-15.
77. Songsivilai, S.; Lachmann, P. J. Bispecific monoclonal antibodies. In Monoclonal Antibodies-Production, Engineering and Clinical Application; Ritter, M., Ladyman, H., Eds.; Cambridge University Press: Cambridge, 1995.
78. Kriangkum, J.; Xu, B. W.; Gervais, C.; Paquette, D.; Jacobs, F. A.; Martin, L.; Suresh, M. R. Development and characterization of a bispecific single-chain antibody directed against T cells and ovarian carcinoma. Hybridoma 2000, 19, 33-41.
79. Schmiedl, A.; Breitling, F.; Dubel, S. Expression of a bispecific dsFv-dsFv' antibody fragment in Escherichia coli. Protein Eng. 2000, 13, 725-734.
80. Zuo, Z.; Jimenez, X.; Witte, L.; Zhu, Z. An efficient route to the production of an IgG-like bispecific antibody. Protein Eng. 2000, 13, 361-367.
81. Lunde, E.; Lauvrak, V.; Rasmussen, I. B.; Schjetne, K. W.; Thompson, K. M.; Michaelsen, T. E.; Brekke, O. H.; Sollid, L. M.; Sandlie, I. Troybodies and Pepbodies. Biochem. Soc. Trans. 2002, 30, 500-506.
82. Adams, G. P.; Schier, R. Generating improved single-chain Fv molecules for tumor targeting. J. Immunol. Methods 1999, 231, 249-260.
83. Hudson, P. J.; Kortt, A. A. High avidity scFv multimers; diabodies and triabodies. J. Immunol. Methods 1999, 231, 177-189.
84. Arndt, K. M.; Muller, K. M.; Pluckthun, A. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment. Biochemistry 1998, 37, 12918-12926.
85. Volkel, T.; Korn, T.; Bach, M.; Muller, R.; Kontermann, R. E. Optimized linker sequences for the expression of monomeric and dimeric bispecific single-chain diabodies. Protein Eng. 2001, 14, 815-823.
86. Kortt, A. A.; Lah, M.; Oddie, G. W.; Gruen, C. L.; Burns, J. E.; Pearce, L. A.; Atwell, J. L.; McCoy, A. J.; Howlett, G. J.; Metzger, D. W.; Webster, R. G.; Hudson, P. J. Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. Protein Eng. 1997, 10, 423-433.
87. Atwell, J. L.; Breheney, K. A.; Lawrence, L. J.; McCoy, A. J.; Kortt, A. A.; Hudson, P. J. scFv multimers of the antineuraminidase antibody NC10: length of the linker between V-H and V-L domains dictates precisely the transition between diabodies and triabodies. Protein Eng. 1999, 12, 597-604.
88. Pei, X. Y.; Holliger, P.; Murzin, A. G.; Williams, R. L. The 2.0-angstrom resolution crystal structure of a trimeric antibody fragment with noncognate V-H-V-L domain pairs shows are arrangement of V-H CDR3. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 9637-9642.
89. McGuiness, B. T.; Walter, G.; FitzGerald, K.; Schuler, P.; Mahoney, W.; Duncan, A. R.; Hoogenboom, H. R. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments. Nat. Biotechnol. 1996, 14, 1149-1154.
90. Power, B. E.; Hudson, P. J. Synthesis of high avidity antibody fragments (scFv multimers) for cancer imaging. J. Immunol. Methods 2000, 242, 193-204.
91. FitzGerald, K.; Holliger, P.; Winter, G. Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastoris. Protein Eng. 1997, 10, 1221-1225.
92. Holliger, P.; Wing, M.; Pound, J. D.; Bohlen, H.; Winter, G. Retargeting serum immunoglobulin with bispecific diabodies. Nat. Biotechnol. 1997, 15, 632-636.
93. Hu, S. Z.; Shivery, L.; Raubitschek, A.; Sherman, M.; Williams, L. E.; Wong, J. Y. C.; Shively, J. E.; Wu, A. M. Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-C(H)3) which exhibits rapid, high-level targeting of xenografts. Cancer Res. 1996, 56, 3055-3061.
94. Martin, F.; Toniatti, C.; Salvati, A. L.; Venturini, S.; Ciliberto, G.; Cortese, R.; Sollazzo, M. The affinity-selection of a minibody polypeptide inhibitor of human interleukin-6. EMBO J. 1994, 13, 5303-5309.
95. Dimasi, N.; Martin, F.; Volpari, C.; Brunetti, M.; Biasiol, G.; Altamura, S.; Cortese, R.; DeFrancesco, R.; Steinkuhler, C.; Sollazzo, M. Characterization of engineered hepatitis C virus NS3 protease inhibitors affinity selected from human pancreatic secretory trypsin inhibitor and minibody repertoires. J. Virol. 1997, 71, 7461-7469.
96. Martin, F.; Steinkuhler, C.; Brunetti, M.; Pessi, A.; Cortese, R.; De Francesco, R.; Sollazzo, M. A loop-mimetic inhibitor of the HCV-NS3 protease derived from a minibody. Protein Eng. 1999, 12, 1005-1011.
97. Schmidt, A.; Muller, D.; Mersmann, M.; Wuest, T.; Gerlach, E.; Garin-Chesa, P.; Rettig, W. J.; Pfizenmaier, K.; Moosmayer, D. Generation of human high-affinity antibodies specific for the fibroplast activation protein by guided selection. Eur. J. Biochem. 2001, 268, 1730-1738.
98. Nord, K.; Nilsson, J.; Nilsson, B.; Uhlen, M.; Nygren, P. A. A combinatorial library of an α-helical bacterial receptor domain. Protein Eng. 1995, 8, 601-608.
99. Nord, K.; Gunneriusson, E.; Ringdahl, J.; Stahl, S.; Uhlen, M.; Nygren, P. A. Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain. Nat. Biotechnol. 1997, 15, 772-777.
100. Nord, K.; Nord, O.; Uhlen, M.; Kelley, B.; Ljungqvist, C.; Nygren, P. A. Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A. Eur. J. Biochem. 2001, 268, 4269-4277.
101. Ronmark, J.; Gronlund, H.; Uhlen, M.; Nygren, P. A. Human immunoglobulin A (IgA)-specific ligands from combinatorial engineering of Protein A. Eur. J. Biochem. 2002, 269, 2647-2655.
102. Vaughan, T. J.; Osbourn, J. K.; Tempest, P. R. Human antibodies by design. Nat. Biotechnol. 1998, 16, 535-539.
103. Chadd, H. E.; Chamow, S. M. Therapeutic antibody expression technology. Curr. Opin. Biotechnol. 2001, 12, 188-194.
104. Larrick, J. W.; Thomas, D. W. Producing proteins in transgenic plants and animals. Curr. Opin. Biotechnol. 2001, 12, 411-418.
105. Pollock, D. P.; Kutzko, J. P.; Birck-Wilson, E.; Williams, J. L.; Echelard, Y.; Meade, H. M. Transgenic milk as a method for the production of recombinant antibodies. J. Immunol. Methods 1999, 231, 147-157.
106. Kuroiwa, Y.; Kasinathan, P.; Choi, Y. J.; Naeem, R.; Tomizuka, K.; Sullivan, E. J.; Knott, J. G.; Duteau, A.; Goldsby, R. A.; Osborne, B. A.; Ishida, I.; Robl, J. M. Cloned transchromosomic calves producing human immunoglobulin. Nat. Biotechnol. 2002, 20, 889-894.
107. Peeters, K.; De Wilde, C.; De Jaegger, G.; Angenon, G.; Depicker, A. Production of antibodies and antibody fragments in plants. Vaccine 2001, 19, 2756-2761.
108. Sharp, J. M.; Doran, P. M. Strategies for enhancing monoclonal antibody accumulation in plant cel and organ cultures. Biotechnol. Prog. 2001, 17, 979-992.
109. Bakker, H.; Bardor, M.; Molthoff, J. W.; Gomord, V.; Elbers, I.; Stevens, L. H.; Jordi, W.; Lommen, A.; Faye, L.; Lerouge, P.; Bosch, D. Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 2899-2904.
110. Humphreys, D. P. Production of antibodies and antibody fragments in Escherichia coli and a comparison of their functions, uses and modification. Curr. Opin. Drug Discovery Dev. 2003, 6, 188-196.
111. Willems, A.; Leoen, J.; Schoonooghe, S.; Grooten, J.; Mertens, N. Optimizing expression and purification from cell culture medium of trispecific recombinant antibody derivatives. J. Chromatogr., B 2003, 786, 161-176.
112. Buchner, J.; Rudolph, R. Routes to active proteins from transformed microorganisms. Curr. Opin. Biotechnol. 1991, 2, 532-538.
113. de Bernardez Clark, E. Refolding of recombinant proteins. Curr. Opin. Biotechnol. 1998, 9, 157-163.
114. Lilie, H.; Schwarz, E.; Rudolph, R. Advances in refolding of proteins produced in E.coli. Curr. Opin. Biotechnol. 1998, 9, 497-501.
115. Tsumoto, K.; Shinoki, K.; Kondo, H.; Uchikawa, M.; Juji, T.; Kumagai, I. Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent-application to a human single-chain Fv. J. Immunol. Methods 1998, 219, 119-129.
116. Besserte, P.; Aslund, F.; Beckwith, J.; Georgiou, G. Efficient folding of proteins with multiple disulfide bonds in the E. coli cytoplasm. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 13703-13708.
117. Takemura, S.; Asano, R.; Tsumoto, K.; Ebara, S.; Sakurai, N.; Katasoye, Y.; Kodama, H.; Yoshida, H.; Suzuki, M.; Imai, K.; Matsuno, S.; Kudo, T.; Kumagai, I. Construction of a diabody (small recombinant bispecific antibody) using a refolding system. Protein Eng. 2000, 13,
118. Naveh, D.; Siegel, R. C. Large scale downstream processing of monoclonal antibodies. Bioseparation 1991, 1, 351-366.
119. Lowe, C. R. Combinatorial approaches to affinity chromatography. Curr. Opin. Chem. Biol. 2001, 5, 248-256.
120. Östlund, C. Large-Scale Purification of Monoclonal Antibodies. Trends Biotechnol. 1996, 166, 288-293.
121. Graf, H.; Rabaud, J. N.; Egly, J. M. Ion-exchange resins for the purification of monoclonal antibodies from animal cell culture. Bioseparation 1994, 4, 7-20.
122. Labrou, N.; Clonis, Y. D. The affinity technology in downstream processing. J. Biotechnol. 1994, 36, 95-119.
123. Castilho, L. R.; Anspach, F. B.; Deckwer, W. D. Comparison of affinity membranes for the purification of immunoglobulins. J. Membr. Sci. 2002, 207, 253-264.
124. Coffinier, Y.; Legallais, C.; Vijayalakshmi, M. A. Separation of IgG from human plasma using thiophilic hollow fiber membranes. J. Membr. Sci. 2002, 208, 13-22.
125. Andrews, B. A.; Nielsen, S.; Asenjo, J. A. Partioning and purification of monoclonal antibodies in aqueous two-phase systems. Bioseparation 1996, 6, 303-313.
126. Zijlstra, G. M.; Michielsen, M. J. F.; de Gooijer, C. D.; van der Pol, L. A.; Tramper, J. IgG and hybridoma partioning in aqueous two-phase systems containing a dye-ligand Bioseparation 1998, 7, 117-126.
127. Lim, S.; Manusu, H. P.; Gooley, A. A.; Williams, K. L.; Rylatt, D. B. Purification of monoclonal antibodies from ascitic fluid using preparative electrophoresis. J. Chromatogr., A 1998, 827, 329-335.
128. Thomas, T. M.; Shave, E. E.; Bate, I. M.; Gee, S. C.; Franklin, S.; Rylatt, D. B. Preparative electrophoresis: a general method for the purification of polyclonal antibodies. J. Chromatogr., A 2002, 944, 161-168.
129. Lee, H. G. Rapid high-performance isoelectric focusing of monoclonal antibodies in uncoated fused-silica capillaries. J. Chromatogr., A 1997, 790, 215-223.
130. Muller, K. M.; Arndt, K. M.; Bauer, K.; Pluckthun, A. Tandem immobilized metal-ion affinity chromatography/immunoaffinity purification of His-tagged proteins - evaluation of two anti-His-tag monoclonal antibodies. Anal. Biochem. 1998, 259, 54-61.
131. Giovannini, R.; Freitag, R. Isolation of a recombinant antibody from cell culture supernatant: continuous annular versus batch and expanded-bed chromatography. Biotechnol. Bioeng. 2001, 73, 522-529.
132. Gottschlich, N.; Kasche, V. Purification of monoclonal antibodies by simulated moving-bed chromatography. J. Chromatogr., A 1997, 765, 201-206.
133. Thommes, J.; Bader, A.; Halfar, M.; Karau, A.; Kula, M. Isolation of monoclonal antibodies from cell containing hybridoma broth using a protein A coated adsorbent in expanded beds. J. Chromatogr., A 1996, 752, 111-122.
134. Dainiak, M. B.; Izumrudov, V.; Muronetz, V. I.; Galaev, I. Y.; Mattiasson, B. Affinity precipitation of monoclonal antibodies by nonstoichiometric polyelectrolyte complexes. Bioseparation 1998, 7, 231-240.
135. Taipa, M. A.; Rajni, K.; Mattiasson, B.; Cabral, J. M. S. Preliminary studies on the purification of a monoclonal antibody by affinity precipitation with Eudragit S-100. J. Mol. Recognit. 1998, 11, 240-242.
136. Taipa, M. A.; Kaul, R.; Mattiasson, B.; Cabral, J. M. S. Recovery of a monoclonal antibody from hybridoma culture supernatant by affinity precipitation with Eudragit S-100. Bioseparation 2001, 9, 291-298.
137. Powers, D. B.; Amersdorfer, P.; Poul, M. A.; Nielsen, U. B.; Shalaby, M. R.; Adams, G. P.; Weiner, L. M.; Marks, J. D. Expression of single-chain Fv-Fc fusions in Pichia pastoris. J. Immunol. Methods 2001, 251, 123-135.
138. Fiedler, M.; Skerra, A. Use of thiophilic adsorption chromatography for the one-step purification of a bacterially produced antibody Fab fragment without the need for an affinity tag. Protein Expression Purif. 1999, 17, 421-427.
139. Holliger, P.; Prospero, T.; Winter, G. "Diabodies": Small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6444-6448.
140. Holliger, P.; Winter, G. Diabodies: small bispecific antibody fragments. Cancer Immunol. Immunother. 1997, 45, 128-130.
141. Peipp, M.; Simon, N.; Loichinger, A.; Baum, W.; Mahr, K.; Zunino, S. J.; Fey, G. H. An improved procedure for the generation of recombinant single-chain Fv antibody fragments reacting with human CD13 on intact cells. J. Immunol. Methods 2001, 251, 161-176.
142. Kaul, R.; Mattiasson, B. Secondary purification. Bioseparation 1992, 3, 1-26.
143. Huse, K.; Bohme, H. J.; Scholz, G. H. Purification of antibodies by affinity chromatography. J. Biochem. Biophys. Methods 2002, 51, 217-231.
144. Hansen, M. B.; Lihme, A.; Spitali, M.; King, D. J. Capture of human Fab fragments by expanded bed adsorption with a mixed mode adsorbent. Bioseparation 1999, 8, 189-193.
145. Ohashi, R.; Otero, J. M.; Chwistek, A.; Yamato, I.; Hamel, J. P. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system. Biotechnol. Prog. 2002, 18, 1292-1300.
146. Zijlstra, G. M.; Michielsen, M. J. F.; de Gooijer, L. A.; van der Pol, L. A.; Tramper, J. Separation of hybridoma cells from their IgG product using aqueous two-phase systems. Bioseparation 1996, 6, 201-210.
147. Kondo, A.; Kaneko, T.; Higashitani, K. Development and application of thermo-sensitive immunomicrospheres for antibody purification. Biotechnol. Bioeng. 1994, 44, 1-6.
148. Anastase-Ravion, S.; Ding, Z.; Pelle, A.; Hoffman, A. S.; Letourneur, D. New antibody purification procedure using a thermally responsive poly-(N-isopropylacrylamide)-dextran derivative conjugate. J. Chromatogr., B 2001, 761, 247-254.
149. Yamanaka, H.; Yoshizako, K.; Akiyama, Y.; Sota, H.; Hasegawa, Y.; Shinohara, Y. Affinity chromatography with collapsibly tethered ligands. Anal. Chem. 2003, 75, 1658-1663.
150. Kwack, K. A new purification method for the Fab and F(ab′)2 fragment of 145-2C11, hamster anti-mouse CD3 epsilon antibody. J. Biochem. Mol. Biol. 2000, 32, 188-192.
151. Nilsson, B.; Moks, T.; Jansson, B.; Abrahmsen, L.; Elmblad, A.; Holmgreen, E.; Henrichson, C.; Jones, T. A.; Uhlen, M. A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1987, 1, 107-113.
152. Braisted, A. C.; Wells, J. A. Minimizing a binding domain from protein A. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 5688-5692.
153. Gulich, S.; Uhlen, M.; Hober, S. Protein engineering of an IgG-binding domain allows milder elution conditions during affinity chromatography. J. Biotechnol. 2000, 76, 233-244.
154. Murray, A.; Sekowski, M.; Spencer, D. I. R.; Denton, G.; Price, M. R. Purification of monoclonal antibodies by epitope and mimotope affinity chromatography. J. Chromatogr., A 1997, 782, 49-54.
155. Murray, A.; Spencer, D. I. R.; Missailidis, S.; Denton, G.; Price, M. R. Design of ligands for the purification of anti-MUC1 antibodies by peptide epitope affinity chromatography. J. Peptide Res. 1998, 52, 375-383.
156. Price, M. R.; Sekowski, M.; Tendler, S. J. Purification of anti-epithelial mucin monoclonal antibodies by epitope affinity chromatography. J. Immunol. Methods 1991, 139, 83-90.
157. Murray, A.; Smith, R. G.; Brady, K.; Williams, S.; Badley, R. A.; Price, M. R. Generation and refinement of peptide mimetic ligands for paratope-specific purification of monoclonal antibodies. Anal. Biochem. 2001, 296, 9-17.
158. Schwartz, W.; Judd, D.; Wysocki, M.; Guerrier, L.; Birck-Wilson, E.; Boschetti, E. Comparison of hydrophobic charge induction chromatography with affinity chromatography on protein A for harvest and purification of antibodies. J. Chromatogr., A 2001, 908, 251-263.
159. Boschetti, E. Antibody separation by hydrophobic charge induction chromatography. Trends Biotechnol. 2002, 20, 333-337.
160. Xu, D.; Leveugle, B.; Kreutz, F. T.; Suresh, M. R. Mimetic ligand-based affinity purification of immune complexes and immunoconjugates. J. Chromatogr., B 1998, 706, 217-229.
161. Husereau, D. R.; Suresh, M. R. A general affinity method to purify peroxidase-tagged antibodies. J. Immunol. Methods 2001, 249, 33-41.
162. Sandin, C.; Linse, S.; Areschoug, T.; Woof, J. M.; Reinholdt, J.; Lindahl, G. Isolation and detection of human IgA using a streptococcal IgA-binding peptide. J. Immunol. 2002, 169, 1357-1364.
163. Fassina, G.; Ruvo, M.; Palombo, G.; Verdoliva, A.; Marino, M. Novel ligands for the affinity-chromatographic purification of antibodies. J. Biochem. Biophys. Methods 2001, 49, 481-490.
164. Fassina, G.; Verdoliva, A.; Odierna, M. R.; Ruvo, M.; Cassini, G. Protein a mimetic peptide ligand for affinity purification of antibodies. J. Mol. Recognit. 1996, 9, 564-569.
165. Li, R. X.; Dowd, V.; Stewart, D. J.; Burton, S. J.; Lowe, C. R. Design, synthesis, and application of a Protein A mimetic. Nat. Biotechnol. 1998, 16, 190-195.
166. Teng, S. F.; Sproule, K.; Husain, A.; Lowe, C. R. Affinity chromatography on immobilized "biomimetic" ligands synthesis, immobilization and chromatographicassessment of an immunoglobulin G-binding ligand. J. Chromatogr., B 2000, 740, 1-15.
167. Lihme, A.; Hansen, M. B. Protein A mimetic for large-scale monoclonal antibody purification. Am. Biotechnol. Lab. 1997, 15, 30-32.
168. Ehrlich, G. K.; Bailon, P. Identification of model peptides as affinity ligands for the purification of humanized monoclonal antibodies by means of phage display. J. Biochem. Biophys. Methods 2001, 49, 443-454.
169. Houghten, R. A.; Pinilla, C.; Blondelle, S. E.; Appel, J. R.; Dooley, C. T.; Cuervo, J. H. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 1991, 354, 84-86.
170. Houghten, R. A.; Dooley, C. T. The use of synthetic peptide combinatorial libraries for the determination of peptide ligands in radio-receptor assays: opioid peptides. Bioorg. Med. Chem. Lett. 1993, 3, 405-412.
171. Houghten, R. A. Soluble chemical combinatorial libraries: Current capabilities and future possibilities. In Peptides-Synthesis, Structures and Applications; Gutte, B., Ed.; Academic Press: London, 1995.
172. Bradbury, A. Molecular library technologies at the millenium. Trends Biotechnol. 2000, 18, 131-133.
173. Cwirla, S. E.; Peters, E. A.; Barrett, R. W.; Dower, W. J. Peptides on phage - A vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 6378-6382.
174. Vanhoorelbeke, K.; van der Plas, R. M.; Vandecasteele, G.; Vauterin, S.; Huizinga, E. G.; Sixma, J. J.; Deckmyn, H. Sequence alignment between vWF and peptides inhibiting the vWF-collagen interaction does not result in the identification of a collagen-binding site in vWF. Thrombosis Haemostasis 2000, 84, 621-625.
175. Denton, G.; Sekowski, M.; Price, M. R. Induction of antibody-responses to breast-carcinoma associated mucins using synthetic peptide constructs as immunogens. Cancer Lett. 1993, 70, 143-150.
176. Lake, D. F.; Schluter, S. F.; Wang, E.; Bernstein, R. M.; Edmundson, A. B.; Marchalonis, J. J. Autoantibodies to the alpha/beta t-cell receptors in human- immunodeficiency-virus infection - Dysregulation and mimicry. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 10849-10853.
177. Price, K. M. Production and characterization of synthetic peptide-derived antibodies. In Monoclonal Antibodies-Production, Engineering and Clinical Application; Ritter, M., Ladyman, H., Eds.; Cambridge University Press: Cambridge, 1995.
178. Palmieri, G.; Cassani, G.; Fassina, G. Peptide immobilization on calcium alginate beads: applications to antibody purification and assay. J. Chromatogr., B 1995, 664, 127-135.
179. Cauwenberghs, N.; Vanhoorelbeke, K.; Vauterin, S.; Westra, D. F.; Rome, G.; Huizinga, E. G.; Lopez, J. A.; Berndt, M. C.; Harsfalvi, J.; Deckmyn, H. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ib alpha reveals interaction between the leucine- rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ib alpha. Blood 2001, 98, 652-660.
180. Cortese, R.; Felici, F.; Galfre, G.; Luzzago, A.; Monaci, P.; Nicosia, A. Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol. 1994, 12, 262-267.
181. Deisenhofer, J. Crystallographic refinement and atomic levels of a human Fc fragment and its complex with fragment B of Protein A from Staphylococcus aureus at 2.9- and 2.8-angstroms resolution. Biochemistry 1981, 20, 2361.
182. Palombo, G.; Verdoliva, A.; Fassina, G. Affinity purification of immunoglobulin M using a novel synthetic ligand. J. Chromatogr., B 1998, 715, 137-145.
183. Verdoliva, A.; Basile, G.; Fassina, G. Affinity purification of immunoglobulins from chicken egg yolk using a new synthetic ligand. J. Chromatogr., B 2000, 749, 233-242.
184. Saragovi, H. U.; Greene, M. I.; Chrusciel, R. A.; Kahn, M. Loops and secondary structure mimetics: development and applications in basic science and rational drug design. BioTechnology 1992, 10, 773-778.
185. Matthews, I. T. W. The design, synthesis and characterization of molecular mimetics. In Epitope Mapping; Westwood, O. M. R., Hay, F. C., Eds.; Oxford University Press: New York, 2000.
186. El-Kak, A.; Vijayalakshmi, M. A. Study of the separation of mouse monoclonal antibodies by pseudobioaffinity chromatography using matrix-linked histidine and histamine. J. Chromatogr. Biomed. Appl. 1991, 570, 29-41.
187. Luo, Q.; Zou, H.; Zhang, Q.; Xiao, X.; Ni, J. High-Performance affinity chromatography with immobilization of protein A and L-histidine on molded monolith. Biotechnol. Bioeng. 2002, 80, 481-489.
188. Ngo, T. T.; Khatter, N. Avid Al, a. synthetic ligand affinity gel mimicking immobilized bacterial antibody receptor for purification of immunoglobulin-G. J. Chromatogr. 1992, 597, 101-109.
189. Anspach, F. B.; Petsch, D.; Deckwer, W. D. Purification of murine IgG(1) on group specific affinity adsorbents. Bioseparation 1996, 6, 165-184.
190. Boschetti, E. The use of thiophilic chromatography for antibody purification: a review. J. Biochem. Biophys. Methods 2001, 49, 361-389.
191. Qadri, F. The reactive triazine dyes: their usefulness and limitations in protein purifications. Trends Biotechnol. 1985, 3, 7-12.
192. Lowe, C. R.; Lowe, A. R.; Gupta, G. New developments in affinity chromatography with potential application in the production of biopharmaceuticals. J. Biochem. Biophys. Methods 2001, 49, 561-574.
193. Teng, S. F.; Sproule, K.; Hussain, A.; Lowe, C. R. A strategy for the generation of biomimetic ligands for affinity chromatography. Combinatorial synthesis and biological evaluation of an IgG binding ligand. J. Mol. Recognit. 1999, 12, 67-75.
194. Wikstrom, M.; Sjobring, U.; Drakenberg, T.; Forsen, S.; Bjorck, L. Mapping of the immunoglobulin light chain-binding site of protein-L. J. Mol. Biol. 1995, 250, 128-133.
195. Beckingham, J. A.; Housden, N. G.; Muir, N. M.; Bottomley, S. P.; Gore, M. G. Studies on a single immunoglobulin-binding domain of protein L from Peptostreptococcus magnus: the role of tyrosine-53 in the reaction with human IgG. Biochem. J. 2001, 353, 395-401.
196. Graille, M.; Stura, E. A.; Housden, N. G.; Beckingham, J. A.; Bottomley, S. P.; Beale, D.; Taussig, M. J.; Sutton, B. J.; Gore, M. G.; Charbonnier, J. B. Complex between Peptostreptococcus magnus protein L and a human antibody reveals structural convergence in the interaction modes of Fab binding proteins. Structure 2001, 9, 679-687.
197. Lowe, C. R.; Roque, A. C. A.; Taipa, M. A. Affinity adsorbents for immunoglobulins. In PCT/GB03/04524203, 2003.